STRUCTURAL CHARACTERIZATION OF TOXIN-BINDING GANGLIOSIDES BY TLC/VC-FTMS
通过 TLC/VC-FTMS 表征毒素结合神经节苷脂的结构
基本信息
- 批准号:8170895
- 负责人:
- 金额:$ 0.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-06-01 至 2011-05-31
- 项目状态:已结题
- 来源:
- 关键词:AffectBindingBiologicalBiological ProcessBiologyCell LineCellsCeramidesComplexComputer Retrieval of Information on Scientific Projects DatabaseCouplingDetectionEndocytosisEpithelial CellsFundingGD1a gangliosideGangliosidesGlycosphingolipidsGrantHumanHydroxylationInstitutionIntestinesKidneyLengthLipidsManuscriptsMembrane MicrodomainsMethodsMonkeysOligosaccharidesPolysaccharidesPreparationProtein FragmentReportingResearchResearch PersonnelResolutionResourcesRoleSamplingSourceStructureSurfaceToxinUnited States National Institutes of HealthVariantVero Cellscholeragen receptorganglioside receptorpreventtrafficking
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Glycosphingolipids and gangliosides participate in diverse biological processes, and their biological roles are dependent on the structures of both the oligosaccharide and the ceramide portions. Here, vibrationally cooled (VC)MALDI-FTMS was used for the detection of labile species followed by their efficient fragmentation by SORI-CAD and IRMPD. GM1 and GD1a gangliosides serve as trafficking receptors for cholera toxin and the related LTIIb toxin, respectively. We assume that GD1a ganglioside of human intestinal cells is not associated with lipid rafts due to its ceramide structural variation, which prevents endocytosis of the LTIIb-GD1a complex. The toxin receptors' ganglioside structures were evaluated as a moderator of this function, including ceramide chain length, level of saturation and hydroxylation, as well as glycan composition. To analyze these molecules, our previously developed method of direct coupling of TLC plates with VC-MALDI-FTMS was used. This allows direct TLC-MALDI-FTMS without adversely affecting the FT high resolution and mass accuracy by the surface irregularity of the TLC plate. Collisional cooling is necessary for stabilization and detection of intact gangliosides. Our earlier reports have described ganglioside purification from polarized intestinal epithelial cell line T-84 and monkey kidney Vero cells and functional studies on the mechanism of toxin biology. The samples were MALDI-desorbed directly off TLC plate surfaces with ~0.2 mm sampling steps. Fragmentation was subsequently performed by SORI-CAD and IRMPD. Both sialylated and highly fucosylated glycosphingolipids were observed. GC/MS analysis of released lipids and glycans were consistent with these observations. A fraction, which could be a protein fragment, that does not migrate on TLC is now being studied, since it also binds with the toxin. Two manuscripts are in preparation.
该副本是利用众多研究子项目之一
由NIH/NCRR资助的中心赠款提供的资源。子弹和
调查员(PI)可能已经从其他NIH来源获得了主要资金,
因此可以在其他清晰的条目中代表。列出的机构是
对于中心,这不一定是调查员的机构。
糖磷脂和神经脂参与了不同的生物学过程,它们的生物学作用取决于寡糖和神经酰胺部分的结构。在这里,振动冷却(VC)MALDI-FTM用于检测不稳定物种,然后通过Sori-Cad和IRMPD有效地分裂。 GM1和GD1A神经毒剂分别用作霍乱毒素和相关LTIIB毒素的运输受体。我们假设人类肠细胞的GD1A神经节因其神经酰胺的结构变异而与脂质筏无关,从而阻止了LTIIB-GD1A复合物的内吞作用。评估毒素受体的神经节结构作为该功能的主持人,包括神经酰胺链长度,饱和度和羟基化水平以及聚糖组成。为了分析这些分子,我们使用了先前开发的TLC板与VC-Maldi-FTM的直接耦合方法。这允许直接TLC-Maldi-FTM,而不会通过TLC板的表面不规则性不利地影响FT高分辨率和质量准确性。碰撞冷却对于稳定和检测完整的神经毒剂是必需的。我们的早期报告描述了从偏振肠上皮细胞系T-84和猴肾细胞中的神经节纯化以及有关毒素生物学机制的功能研究。将样品直接从TLC板板表面直接使用MALDI索引,并采样〜0.2 mm采样步骤。随后由Sori-CAD和IRMPD进行碎片。观察到溶解和高度葡萄糖基化的糖磷脂脂。释放脂质和聚糖的GC/MS分析与这些观察结果一致。现在正在研究未在TLC上迁移的蛋白质片段的馏分,因为它也与毒素结合。准备两个手稿。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WAYNE I LENCER其他文献
WAYNE I LENCER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WAYNE I LENCER', 18)}}的其他基金
Mechanisms of action for the IBD-risk gene INAVA: an epithelial guard receptor for inflammation and integrity of the intestinal barrier
IBD 风险基因 INAVA 的作用机制:炎症和肠道屏障完整性的上皮保护受体
- 批准号:
10214604 - 财政年份:2020
- 资助金额:
$ 0.46万 - 项目类别:
Mechanisms of action for the IBD-risk gene INAVA: an epithelial guard receptor for inflammation and integrity of the intestinal barrier
IBD 风险基因 INAVA 的作用机制:炎症和肠道屏障完整性的上皮保护受体
- 批准号:
10626015 - 财政年份:2020
- 资助金额:
$ 0.46万 - 项目类别:
Mechanisms of action for the IBD-risk gene INAVA: an epithelial guard receptor for inflammation and integrity of the intestinal barrier
IBD 风险基因 INAVA 的作用机制:炎症和肠道屏障完整性的上皮保护受体
- 批准号:
10405643 - 财政年份:2020
- 资助金额:
$ 0.46万 - 项目类别:
Intestinal Disease-enterocyte toxin interaction
肠道疾病-肠细胞毒素相互作用
- 批准号:
9263933 - 财政年份:2016
- 资助金额:
$ 0.46万 - 项目类别:
Intestinal Disease-enterocyte toxin interaction
肠道疾病-肠细胞毒素相互作用
- 批准号:
9167689 - 财政年份:2016
- 资助金额:
$ 0.46万 - 项目类别:
Intestinal Disease-enterocyte toxin interaction
肠道疾病-肠细胞毒素相互作用
- 批准号:
9899224 - 财政年份:2016
- 资助金额:
$ 0.46万 - 项目类别:
STRUCTURAL CHARACTERIZATION OF TOXIN-BINDING GANGLIOSIDES BY TLC/VC-FTMS
通过 TLC/VC-FTMS 表征毒素结合神经节苷脂的结构
- 批准号:
8365529 - 财政年份:2011
- 资助金额:
$ 0.46万 - 项目类别:
Unsaturated glycoceramide as novel platform for mucosal vaccine and drug delivery
不饱和甘油酰胺作为粘膜疫苗和药物输送的新平台
- 批准号:
8145606 - 财政年份:2010
- 资助金额:
$ 0.46万 - 项目类别:
Unsaturated glycoceramide as novel platform for mucosal vaccine and drug delivery
不饱和甘油酰胺作为粘膜疫苗和药物输送的新平台
- 批准号:
8030610 - 财政年份:2010
- 资助金额:
$ 0.46万 - 项目类别:
FcRn-dependent sorting of IgG and IgG-opsinized antigens by epithelial cells
上皮细胞对 IgG 和 IgG 视蛋白化抗原的 FcRn 依赖性分选
- 批准号:
8538945 - 财政年份:2009
- 资助金额:
$ 0.46万 - 项目类别:
相似国自然基金
氮沉降影响南亚热带森林土壤颗粒和矿物结合态碳库蓄存的微生物学机制
- 批准号:32301366
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
分子间电荷转移的精确模拟及其对生物体系中二价金属与配体结合的影响
- 批准号:
- 批准年份:2020
- 资助金额:63 万元
- 项目类别:面上项目
hsa_circ_0128533竞争性结合miR-145通过PI3K/AKT信号通路影响葡萄膜黑色素瘤生物学行为及作用机制的研究
- 批准号:
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
KIAA0247结合E3连接酶WWP1调控Notch信号通路机制及对肺癌生物学行为的影响
- 批准号:81902337
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
生物炭-土壤矿物质界面结合机制及其对碳稳定性的影响
- 批准号:41907016
- 批准年份:2019
- 资助金额:27.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Small Molecule Degraders of Tryptophan 2,3-Dioxygenase Enzyme (TDO) as Novel Treatments for Neurodegenerative Disease
色氨酸 2,3-双加氧酶 (TDO) 的小分子降解剂作为神经退行性疾病的新疗法
- 批准号:
10752555 - 财政年份:2024
- 资助金额:
$ 0.46万 - 项目类别:
The mechanism of CELF1 upregulation and its role in the pathogenesis of Myotonic Dystrophy Type 1
CELF1上调机制及其在强直性肌营养不良1型发病机制中的作用
- 批准号:
10752274 - 财政年份:2024
- 资助金额:
$ 0.46万 - 项目类别:
Causes and Downstream Effects of 14-3-3 Phosphorylation in Synucleinopathies
突触核蛋白病中 14-3-3 磷酸化的原因和下游影响
- 批准号:
10606132 - 财政年份:2024
- 资助金额:
$ 0.46万 - 项目类别:
Role of Frizzled 5 in NK cell development and antiviral host immunity
Frizzled 5 在 NK 细胞发育和抗病毒宿主免疫中的作用
- 批准号:
10748776 - 财政年份:2024
- 资助金额:
$ 0.46万 - 项目类别:
Maternal immune activation remodeling of offspring glycosaminoglycan sulfation patterns during neurodevelopment
神经发育过程中后代糖胺聚糖硫酸化模式的母体免疫激活重塑
- 批准号:
10508305 - 财政年份:2023
- 资助金额:
$ 0.46万 - 项目类别: